Evidence map›Paper›PMID 40883260›Full record

ArticleNature communications2025

UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation.

Melanie Loix, Sam Vanherle, Laura Bolkaerts, Sanne G S Verberk, Mattijs Punt, Flore Wouters, Brecht Moonen, Rob Verhagen, Suzanne A E Van Wouw, Aldo Jongejan and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Research Status and Latest Progress in the Regulatory Mechanisms of ABCA1.International journal of molecular sciences · 2025
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Melanie LoixBiomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium.
Sam VanherleBiomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium.
Laura BolkaertsBiomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium.ORCID http://orcid.org/0000-0002-6101-2748
Sanne G S VerberkBiomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium.ORCID http://orcid.org/0000-0003-4509-4824
Mattijs PuntDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Flore WoutersBiomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium.
Brecht MoonenBiomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium.
Rob VerhagenDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Suzanne A E Van WouwDepartment of Medical Biochemistry, Amsterdam University Medical Center, Amsterdam Institutes of Cardiovascular Sciences and Gastroenterology Endocrinology and Metabolism, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0003-2508-2295
Aldo JongejanBioinformatics Laboratory, Academic University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0002-8948-2549
Ben DistelDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.
Ype ElgersmaDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-3758-1297
Mansour HaidarBiomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium.
Noam ZelcerDepartment of Medical Biochemistry, Amsterdam University Medical Center, Amsterdam Institutes of Cardiovascular Sciences and Gastroenterology Endocrinology and Metabolism, University of Amsterdam, Amsterdam, The Netherlands.ORCID http://orcid.org/0000-0001-6935-7532
Jerome J A Hendriks *Biomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium.ORCID http://orcid.org/0000-0002-7717-8582
Jeroen F J Bogie *Biomedical Research Institute, School of Life Sciences, Hasselt University, Diepenbeek, Belgium. jeroen.bogie@uhasselt.be.ORCID http://orcid.org/0000-0002-0016-1926

Funding

Fondation Charcot (Charcot Foundation) CHARCO23BJ, CHARCO24BJ
6 · The paper itself

Abstract

The accumulation of foamy macrophages is a pathological hallmark of demyelinating brain disorders. Perturbed metabolism and efflux of intracellular lipids underlie the development of a harmful foamy macrophage phenotype in these disorders, yet, the molecular mechanisms underlying this dysregulation are poorly understood. Here, we show that the ubiquitin-proteasome system controls the turnover of the cholesterol efflux transporter ATP-binding cassette A1 (ABCA1) in lipid-loaded macrophages in the brain. We report that accumulation of myelin-derived lipids promotes the abundance and activity of ubiquitin-protein E3 ligase A (UBE3A) in macrophages, which stimulates ABCA1 ubiquitination and subsequent degradation. This boosts cellular lipid accumulation and induces an inflammatory macrophage phenotype that impairs remyelination. We further establish Tat-interacting protein 30 (TIP30), an inhibitor of importin β-mediated nuclear import, as an essential regulator of cytosolic UBE3A levels. Together, our findings identify UBE3A as a driver of foam cell formation and indicate that targeting UBE3A-mediated ABCA1 degradation is a promising strategy to enhance central nervous system repair.

Indexed as

ATP Binding Cassette Transporter 1Foam CellsProteasome Endopeptidase ComplexRemyelinationUbiquitin-Protein LigasesAnimalsBrainHumansMaleMiceMice, Inbred C57BLMice, KnockoutMyelin SheathProteolysisUbiquitinationAbca1 protein, mouseATP Binding Cassette Transporter 1Proteasome Endopeptidase ComplexUbiquitin-Protein Ligases

Identifiers

PMID40883260
PMCPMC12397220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.